Clearstead Trust LLC Has $274,000 Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Clearstead Trust LLC grew its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 60.9% in the 4th quarter, HoldingsChannel reports. The fund owned 8,344 shares of the company’s stock after purchasing an additional 3,157 shares during the quarter. Clearstead Trust LLC’s holdings in ARK Genomic Revolution ETF were worth $274,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of ARKG. Operose Advisors LLC acquired a new stake in shares of ARK Genomic Revolution ETF in the third quarter valued at approximately $25,000. Stephens Consulting LLC acquired a new stake in shares of ARK Genomic Revolution ETF in the third quarter valued at approximately $28,000. Allworth Financial LP raised its position in ARK Genomic Revolution ETF by 65.3% during the third quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock valued at $40,000 after purchasing an additional 563 shares in the last quarter. Naples Money Management LLC acquired a new position in ARK Genomic Revolution ETF during the fourth quarter valued at approximately $63,000. Finally, BKM Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF during the fourth quarter valued at approximately $78,000.

ARK Genomic Revolution ETF Price Performance

ARKG traded up $0.85 during trading on Friday, hitting $25.04. 4,481,666 shares of the stock traded hands. The business’s fifty day moving average is $27.40 and its 200 day moving average is $28.32.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.